Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing.
Abusamra SM, Solorzano MA, Quarles J, Luke M, Patel M, Vince R Jr, Jiang R, Volin J, Jacobs MF, Kaffenberger SD, Salami SS, Palmbos P, Caram MEV, Hollenbeck BK, Palapattu GS, Merajver SD, Stoffel EM, Hafron J, Morgan TM, Reichert ZR. Abusamra SM, et al. Among authors: reichert zr. Urol Pract. 2025 Jan;12(1):63-72. doi: 10.1097/UPJ.0000000000000727. Epub 2024 Oct 9. Urol Pract. 2025. PMID: 39383006
Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer.
Abusamra SM, Solorzano MA, Luke M, Quarles J, Jacobs MF, Das S, Kasputis A, Okoth LA, Patel M, Seymore M, Caram MEV, Dunn RL, Merajver SD, Stoffel EM, Reichert ZR, Morgan TM. Abusamra SM, et al. Among authors: reichert zr. J Urol. 2022 Nov;208(5):1007-1017. doi: 10.1097/JU.0000000000002865. Epub 2022 Aug 5. J Urol. 2022. PMID: 35930793 Free PMC article.
Understanding the Barriers to Neoadjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer: A Quality Improvement Initiative.
Andino JJ, Sessine M, Singhal U, Reichert ZR, Wray D, Shafer C, Moore M, Weizer AZ, Kaffenberger SD, Herrel LA, Morgan TM, Hafez KZ, Montgomery JS. Andino JJ, et al. Among authors: reichert zr. Urol Pract. 2021 Mar;8(2):217-225. doi: 10.1097/UPJ.0000000000000200. Epub 2020 Oct 14. Urol Pract. 2021. PMID: 33655019 Free PMC article.
Reply by Authors.
Abusamra SM, Solorzano MA, Luke M, Quarles J, Jacobs MF, Das S, Kasputis A, Okoth LA, Patel M, Seymore M, Caram MEV, Dunn RL, Merajver SD, Stoffel EM, Reichert ZR, Morgan TM. Abusamra SM, et al. Among authors: reichert zr. J Urol. 2022 Nov;208(5):1016-1017. doi: 10.1097/JU.0000000000002865.02. Epub 2022 Aug 19. J Urol. 2022. PMID: 35984085 No abstract available.
Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer.
Chung JS, Wang Y, Henderson J, Singhal U, Qiao Y, Zaslavsky AB, Hovelson DH, Spratt DE, Reichert Z, Palapattu GS, Taichman RS, Tomlins SA, Morgan TM. Chung JS, et al. Neoplasia. 2019 Aug;21(8):802-809. doi: 10.1016/j.neo.2019.06.002. Epub 2019 Jul 2. Neoplasia. 2019. PMID: 31276932 Free PMC article.
Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Reichert ZR, Kasputis T, Nallandhighal S, Abusamra SM, Kasputis A, Haruray S, Wang Y, Williams S, Singhal U, Alva A, Cackowski FC, Caram MEV, Palmbos PL, Yentz SE, Smith DC, Alumkal JJ, Morgan TM. Reichert ZR, et al. Int J Mol Sci. 2021 Dec 21;23(1):4. doi: 10.3390/ijms23010004. Int J Mol Sci. 2021. PMID: 35008431 Free PMC article.
Reply by Authors.
Andino JJ, Sessine M, Singhal U, Reichert ZR, Wray D, Shafer C, Moore M, Weizer AZ, Kaffenberger SD, Herrel LA, Morgan TM, Hafez KZ, Montgomery JS. Andino JJ, et al. Among authors: reichert zr. Urol Pract. 2021 Mar;8(2):225. doi: 10.1097/UPJ.0000000000000200.03. Urol Pract. 2021. PMID: 37064605 Free PMC article. No abstract available.
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome.
Abdulfatah E, Reichert ZR, Davenport MS, Chinnaiyan AM, Dadhania V, Wang X, Mannan R, Kunju LP, Hollenbeck BK, Montgomery JS, Kaffenberger SD, Morgan TM, Alva AS, Palapattu GS, Vaishampayan UN, Alumkal JJ, Spratt DE, Udager AM, Mehra R. Abdulfatah E, et al. Among authors: reichert zr. Med Oncol. 2021 Feb 14;38(3):26. doi: 10.1007/s12032-021-01473-2. Med Oncol. 2021. PMID: 33586037
50 results